H.R. 7174 · 118th Congress

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Introduced on Jan 31, 2024 by Gregory F. Murphy (R-NC-3). 17 cosponsors, 2 of them from another party. Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
Jan 31, 2024
Cosponsors
17
2 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Gregory F. MurphyR-NC-3Sponsor

Democrats · 2

Republicans · 15

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jan 31, 2024Introduced in House
  2. Jan 31, 2024Introduced in House
  3. Jan 31, 2024 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Jan 31, 2024 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Dec 17, 2024 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PFIZER INC.5 reports
    $8.9M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  2. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA5 reports
    $31M reported (all issues)
  3. ACADIA PHARMACEUTICALS4 reports
    $1.4M reported (all issues)
  4. AMGEN INC.4 reports
    $11.6M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  5. BIOTECHNOLOGY INNOVATION ORGANIZATION4 reports
    $6.7M reported (all issues)
  6. GSK (fka GLAXOSMITHKLINE INC.)4 reports
    $4.8M reported (all issues)
  7. HealthCare Institute of New Jersey4 reports
    $214.1K reported (all issues)
  8. INTRA-CELLULAR THERAPIES, INC.4 reports
    $210K reported (all issues)
  9. NEUROCRINE BIOSCIENCES, INC.4 reports
    $3.3M reported (all issues)Federal contractor: NEUROCRINE BIOSCIENCES, INC.AI match · 100%
  10. NOVARTIS CORPORATION4 reports
    $6M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  11. PTC THERAPEUTICS, INC.4 reports
    $760K reported (all issues)
  12. Pharmaceutical Research and Manufacturers of America (PhRMA)4 reports
    $120K reported (all issues)
  13. SANOFI US SERVICES INC4 reports
    $5.5M reported (all issues)
  14. Bayer Corporation (consolidated report)3 reports
    $6.2M reported (all issues)
  15. HARMONY BIOSCIENCES, LLC3 reports
    $450K reported (all issues)Federal contractor: HARMONY BIOSCIENCES LLC$614.4K in contracts, FY2026AI match · 100%
  16. JOHNSON & JOHNSON SERVICES, INC.3 reports
    $5M reported (all issues)
  17. LUNDBECK LLC3 reports
    $420K reported (all issues)Federal contractor: LUNDBECK LLCAI match · 99%
  18. MERCK & CO., INC.3 reports
    $7M reported (all issues)Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  19. TAKEDA PHARMACEUTICALS AMERICA, INC.3 reports
    $1.9M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  20. Personalized Medicine Coalition2 reports
    $85K reported (all issues)
  21. Healthcare Leadership Council1 report
    $110K reported (all issues)
  22. OTSUKA AMERICA PHARMACEUTICAL, INC1 report
    $310K reported (all issues)Federal contractor: OTSUKA AMERICA PHARMACEUTICAL INCAI match · 100%
  23. Public Citizen1 report
    $88K reported (all issues)

Reports filed in 2024.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.